Athira Pharma Inc ATHA:NASDAQ

Last Price$12.34NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$12.33 (3)
Ask (Size)$14.00 (3)
Day Low / HighN/A - N/A
Volume502.6 K
 

Read more news Recent News

Athira Pharma Discloses Update From Trials of ATH-1017 For Alzheimer's Disease Treatment
1:48PM ET 11/10/2021 MT Newswires

Athira Pharma (ATHA) disclosed Wednesday an update from its trials of lead development candidate ATH-1017 for treatment of mild to moderate Alzheimer's...

Athira Pharma Completes Enrollment in Study of Potential Alzheimer's Treatment; Shares Rise Pre-Bell
9:15AM ET 10/22/2021 MT Newswires

Athira Pharma (ATHA) said Friday it has completed enrollment in a phase 2 study of ATH-1017 in patients with mild-to-moderate Alzheimer's disease. ATH-1017...

Sector Update: Health Care Stocks Relatively Flat Premarket Friday
8:55AM ET 10/22/2021 MT Newswires

Health care stocks were relatively flat ahead of Friday's opening bell. The Health Care SPDR (XLV) was up 0.2% while the iShares NASDAQ Biotechnology Index...

Sector Update: Health Care
8:20AM ET 10/22/2021 MT Newswires

Health care stocks inched higher ahead of Friday's opening bell. The Health Care SPDR (XLV) was up 0.2% while the iShares NASDAQ Biotechnology Index (IBB)...

View all Commentary and Analysis

Athira Pharma - ATH-1017: Panacea Or Pandora's Box?
11:19AM ET 6/30/2021 Seeking Alpha

Athira Pharma: What, Exactly, Did The CEO Do?
6:19AM ET 6/29/2021 Seeking Alpha

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2021 Update
4:33AM ET 6/18/2021 Seeking Alpha

Synaptogenix: The Next Big Thing In Alzheimer's
4:06PM ET 6/16/2021 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/24/2021EFFECT

Company Highlights

Price Open$13.12
Previous Close$13.07
52 Week Range$8.88 - 34.79
Market Capitalization$460.9 M
Shares Outstanding37.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.28
Beta vs. S&P 500N/A
RevenueN/A
Net Profit MarginN/A
Return on Equity-13.96%

Analyst Ratings as of 10/27/2021

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset